139 related articles for article (PubMed ID: 3593986)
1. Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma.
Dilley WG; Haagensen DE; Leight GS; Ammirata S; Davis SR; Silva JS; Zamcheck N; Lokich JJ; Wells SA
Breast Cancer Res Treat; 1986; 8(3):205-15. PubMed ID: 3593986
[TBL] [Abstract][Full Text] [Related]
2. Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma.
Dilley WG; Leight GS; Silva JS; Ammirata S; Haagensen DE; Wells SA
J Natl Cancer Inst; 1983 Jan; 70(1):69-74. PubMed ID: 6571924
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Drago J; Rohner T; Haagensen D; Glode M; Santner SJ
Anticancer Res; 1984; 4(3):141-4. PubMed ID: 6380398
[TBL] [Abstract][Full Text] [Related]
4. The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.
Haagensen DE; Barry WF; McCook TA; Giannola J; Ammirata S; Wells SA
Ann Surg; 1980 May; 191(5):599-603. PubMed ID: 7369822
[TBL] [Abstract][Full Text] [Related]
5. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
[TBL] [Abstract][Full Text] [Related]
6. Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones.
Haagensen DE; Stewart P; Dilley WG; Wells SA
Breast Cancer Res Treat; 1992; 23(1-2):77-86. PubMed ID: 1446056
[TBL] [Abstract][Full Text] [Related]
7. Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer.
Dumont M; Dauvois S; Simard J; Garcia T; Schachter B; Labrie F
J Steroid Biochem; 1989; 34(1-6):397-402. PubMed ID: 2626033
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.
Simard J; Hatton AC; Labrie C; Dauvois S; Zhao HF; Haagensen DE; Labrie F
Mol Endocrinol; 1989 Apr; 3(4):694-702. PubMed ID: 2725533
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma.
Haagensen DE; Kister SJ; Panick J; Giannola J; Hansen HJ; Wells SA
Cancer; 1978 Sep; 42(3 Suppl):1646-52. PubMed ID: 709529
[TBL] [Abstract][Full Text] [Related]
10. Biochemical correlates of morphologic differentiation in human breast cancer.
Silva JS; Cox CE; Wells SA; Paull D; Dilley WG; McCarty KS; Fetter BF; Glaubitz LC; McCarty KS
Surgery; 1982 Sep; 92(3):443-9. PubMed ID: 7202259
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of hormonal therapy in patients with metastatic breast carcinoma by plasma marker protein profiles.
Haagensen DE; Dilley WG; Cox CE; Giannola JE; Wells SA
Surg Forum; 1978; 29():162-4. PubMed ID: 401123
[TBL] [Abstract][Full Text] [Related]
13. Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer.
Bundred NJ; Stewart HJ; Shaw DA; Forrest AP; Miller WR
Eur J Cancer; 1990; 26(11-12):1145-7. PubMed ID: 2149996
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells.
Blais Y; Sugimoto K; Carrière MC; Haagensen DE; Labrie F; Simard J
Int J Cancer; 1995 Sep; 62(6):732-7. PubMed ID: 7558422
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells.
Dauvois S; Simard J; Dumont M; Haagensen DE; Labrie F
Mol Cell Endocrinol; 1990 Oct; 73(2-3):171-8. PubMed ID: 2269395
[TBL] [Abstract][Full Text] [Related]
16. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells.
Cassoni P; Sapino A; Haagensen DE; Naldoni C; Bussolati G
Int J Cancer; 1995 Jan; 60(2):216-20. PubMed ID: 7829219
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
Selim AA; El-Ayat G; Wells CA
Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
[TBL] [Abstract][Full Text] [Related]
18. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
[TBL] [Abstract][Full Text] [Related]
19. Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein.
Haagensen DE; Gall SA; Brazy JE; Giannola J; Wells SA
Am J Obstet Gynecol; 1980 Sep; 138(1):25-32. PubMed ID: 7416203
[TBL] [Abstract][Full Text] [Related]
20. Breast gross cystic disease protein 15 in human breast cancer in culture.
Miller WR; Shivas AA; Franchimont P; Haagensen DE
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):223-8. PubMed ID: 3356211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
